Management and costs of chronic pulmonary obstructive disease in France in 2011
Copyright © 2014 SPLF. Published by Elsevier Masson SAS. All rights reserved..
OBJECTIVES: To estimate the prevalence of treated chronic obstructive pulmonary disease (COPD) and its associated costs by stage of severity.
METHODS: The study was conducted on the 2011 data of the french general beneficiary sample database (EGB). EGB is a 1/97th sample of the whole population of the beneficiaries of the main compulsory national health insurances. COPD cases and the level of severity of the disease have been identified using new algorithms established from the available parameters in EGB. Costs were estimated using a collective perspective.
RESULTS: The minimal prevalence of treated COPD was estimated at 3.8% in patients of 40 years and older and 1.9% regardless of the age of individuals. This population was predominantly male (58.2%) with a mean age of 68.8 years (±12.7). A total of 6.2% of patients had a health-care utilization suggestive of a very severe stage of COPD and 8.1%, 13.8% and 71.9% suggestive of severe, moderate and mild stages respectively. Over one year, 28.8% of patients visited a specialist respiratory physician, 5.0% were hospitalized (≥24h) for COPD and 6.7% died. Patients experienced an average of 1.7 (±1.5) exacerbations per year and only 61.4% received specific pharmacological treatment for COPD during the year. The average yearly health-care cost of a patient with COPD was estimated at €9382, with €5342 directly related to COPD.
CONCLUSION: This study based on medico-administrative databases confirms the high epidemiological and economic burden of COPD in France.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
|---|---|
| Enthalten in: |
Revue des maladies respiratoires - 32(2015), 7 vom: 01. Sept., Seite 682-91 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Prise en charge et coûts de la bronchopneumopathie chronique obstructive en France en 2011 |
|---|
| Beteiligte Personen: |
Laurendeau, C [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 29.06.2016 Date Revised 09.04.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.rmr.2014.10.731 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM245579796 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM245579796 | ||
| 003 | DE-627 | ||
| 005 | 20231224141200.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2015 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.rmr.2014.10.731 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0818.xml |
| 035 | |a (DE-627)NLM245579796 | ||
| 035 | |a (NLM)25613440 | ||
| 035 | |a (PII)S0761-8425(14)01235-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Laurendeau, C |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Management and costs of chronic pulmonary obstructive disease in France in 2011 |
| 246 | 3 | 3 | |a Prise en charge et coûts de la bronchopneumopathie chronique obstructive en France en 2011 |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.06.2016 | ||
| 500 | |a Date Revised 09.04.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2014 SPLF. Published by Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a OBJECTIVES: To estimate the prevalence of treated chronic obstructive pulmonary disease (COPD) and its associated costs by stage of severity | ||
| 520 | |a METHODS: The study was conducted on the 2011 data of the french general beneficiary sample database (EGB). EGB is a 1/97th sample of the whole population of the beneficiaries of the main compulsory national health insurances. COPD cases and the level of severity of the disease have been identified using new algorithms established from the available parameters in EGB. Costs were estimated using a collective perspective | ||
| 520 | |a RESULTS: The minimal prevalence of treated COPD was estimated at 3.8% in patients of 40 years and older and 1.9% regardless of the age of individuals. This population was predominantly male (58.2%) with a mean age of 68.8 years (±12.7). A total of 6.2% of patients had a health-care utilization suggestive of a very severe stage of COPD and 8.1%, 13.8% and 71.9% suggestive of severe, moderate and mild stages respectively. Over one year, 28.8% of patients visited a specialist respiratory physician, 5.0% were hospitalized (≥24h) for COPD and 6.7% died. Patients experienced an average of 1.7 (±1.5) exacerbations per year and only 61.4% received specific pharmacological treatment for COPD during the year. The average yearly health-care cost of a patient with COPD was estimated at €9382, with €5342 directly related to COPD | ||
| 520 | |a CONCLUSION: This study based on medico-administrative databases confirms the high epidemiological and economic burden of COPD in France | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Base de données | |
| 650 | 4 | |a Bronchopneumopathie chronique obstructive | |
| 650 | 4 | |a Chronic obstructive pulmonary disease | |
| 650 | 4 | |a Coûts des soins | |
| 650 | 4 | |a Database | |
| 650 | 4 | |a France | |
| 650 | 4 | |a Health-care costs | |
| 650 | 4 | |a Index de sévérité de la maladie | |
| 650 | 4 | |a Severity of illness Index | |
| 700 | 1 | |a Chouaid, C |e verfasserin |4 aut | |
| 700 | 1 | |a Roche, N |e verfasserin |4 aut | |
| 700 | 1 | |a Terrioux, P |e verfasserin |4 aut | |
| 700 | 1 | |a Gourmelen, J |e verfasserin |4 aut | |
| 700 | 1 | |a Detournay, B |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revue des maladies respiratoires |d 1988 |g 32(2015), 7 vom: 01. Sept., Seite 682-91 |w (DE-627)NLM012622443 |x 1776-2588 |7 nnns |
| 773 | 1 | 8 | |g volume:32 |g year:2015 |g number:7 |g day:01 |g month:09 |g pages:682-91 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.rmr.2014.10.731 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 32 |j 2015 |e 7 |b 01 |c 09 |h 682-91 | ||